Related Experiment Video

Updated: Jun 20, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

The distinct role of secondary prevention in patients with prior coronary interventions

Humberto Colmenarez1, Javier Escaned

  • 1Instituto Cardiovascular, Unidad de Hemodinámica, Hospital Clinico San Carlos, Madrid, Spain. sirius_stent@yahoo.com

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
|September 9, 2009
PubMed

Insights

Secondary prevention is crucial for managing coronary artery disease, especially after interventions. Optimizing its implementation can prevent repeat revascularisation and improve patient outcomes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Preventive Cardiology

Background:

  • Secondary prevention is vital in coronary artery disease (CAD) management.
  • Its role is distinct in patients with prior coronary interventions, impacting atherosclerosis, graft attrition, and post-revascularisation events.
  • It serves as a protective measure against repeat revascularisation procedures.

Purpose of the Study:

  • To highlight the distinct role of secondary prevention in patients with prior coronary interventions.
  • To emphasize its function in preventing adverse events and repeat revascularisation.
  • To underscore the need for a comprehensive approach to coronary revascularisation.

Main Methods:

  • Review of existing literature on secondary prevention in CAD.
  • Analysis of the impact of secondary prevention on atherosclerosis progression and graft attrition.
  • Evaluation of secondary prevention's role in reducing adverse events post-percutaneous revascularisation.

Main Results:

  • Secondary prevention significantly affects native atherosclerosis progression and saphenous vein graft attrition.
  • It reduces adverse events following percutaneous revascularisation.
  • Implementation of secondary prevention remains suboptimal in clinical practice.

Conclusions:

  • Secondary prevention is a critical strategy to prevent repeat revascularisation in patients with prior interventions.
  • A comprehensive approach integrating secondary prevention into coronary revascularisation is essential.
  • Improving the clinical implementation of secondary prevention strategies is paramount for better patient outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...